| Bioactivity | LX-6171 is an orally active SLC6A7 inhibitor. LX-6171 can be used to study diseases characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia or vascular dementia[1]. |
| Target | SLC6A7 |
| CAS | 914808-66-5 |
| Formula | C22H20ClN3O |
| Molar Mass | 377.87 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. |